Latest News about FDA
Recent news which mentions FDA
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
From Benzinga
Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes
December 04, 2023
From Benzinga
Congressional Report Sheds Light On Hemp's Impact And Future Prospects Amid Farm Bill Renewal Talks
December 04, 2023
From Benzinga
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
December 04, 2023
Tickers
ETNB
From Benzinga
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
November 29, 2023
Tickers
VVOS
From Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study
November 28, 2023
Tickers
ALDX
From Benzinga
FDA Approves SpringWorks Therapeutics' Lead Therapy As First For Subtype Of Soft Tissue Sarcomas
November 28, 2023
Tickers
SWTX
From Benzinga
Why Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?
November 27, 2023
Tickers
RDHL
From Benzinga
Why Is Neuromuscular Disease Focused Entrada Therapeutics Shares Trading Lower Today?
November 22, 2023
Tickers
TRDA
From Benzinga
Why Is Pharma Giant Bristol-Myers Squibb Stock Trading Lower Today?
November 20, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free